Content strategy for agencies: how to productise the offering for healthcare and life sciences in Latin America
The service design, pricing, and delivery model for running content strategy as a productised offering inside a services firm. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Latin America.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install content strategy has to be shaped to that reality from day one.
Content strategy is one of the highest-margin offerings an agency can add in 2026. It is publishing what your buyer needs to move a decision, not what the CMS quota demands, and clients will pay a premium for the discipline they cannot install themselves.
Productise around outcome, not activity. Sell pieces cited by prospects during sales calls moving to a defined level in a defined window, not a monthly retainer of vague ops.
Delivery pod: one strategist, one operator, one editor. Fewer people than that risks quality; more than that dilutes margin.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Content strategy is only useful here when it is pointed at both constraints at once.
Onboarding takes two weeks: diagnosis, list build, trigger definition, kill criteria. Do not ship anything live before the diagnosis is signed off.
Pricing: outcome-linked base plus a monthly ops fee. The base rewards results; the ops fee funds the delivery pod.
Client failure mode: confusing volume with authority. Write it into the engagement letter as a shared risk, not something you absorb quietly.
The agencies making the most from content strategy are the ones with the tightest playbook. Documented, versioned, and improved every quarter.
Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing content strategy deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Content · healthcare · LATAM — answered
- Does content strategy work for healthcare and life sciences in Latin America?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms. The healthcare teams that install this get past procurement instead of dying in it.
- How should agencies price content strategy?
- Outcome-linked base plus a monthly ops fee. Avoid pure retainer.
- What is the minimum delivery pod?
- Strategist, operator, editor. Three roles, not necessarily three headcount at small scale.
- How long is agency onboarding for content strategy?
- Two weeks: diagnosis, list, trigger, kill criteria.
- What client behaviour breaks the engagement?
- Confusing volume with authority — bake shared risk into the contract.
- What is the LATAM-specific pitfall when running content strategy for healthcare?
- Importing a playbook that was built for another market. In Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms — the install has to reflect that.
Growth Broker editorial
Filed under content · healthcare · latam